Call for NHS to reduce antibiotic use to 2010 levels NHS must commit to national targets to use fewer antibiotics to halt the rise in antimicrobial resistance, according to a coalition of health professional bodies.…
Chemical screening unearths tannic acid as candidate for cystic fibrosis therapy Researchers have found that tannic acid is able to act against Staphylococcus aureus, a major cause of infection in cystic fibrosis.…
Research confirms faecal microbiota transplantation is safe and effective An age-old treatment has shown remarkable clinical cure rates for Clostridium difficile infection, achieving far better outcomes than antimicrobial therapy.…
Effective treatments lagging behind for multidrug-resistant TB, says WHO There are still major gaps in delivering effective treatments to patients suffering from multidrug-resistant tuberculosis, a report finds.…
Not every problem is viral We must not allow fears about Ebola and other viruses to obscure the threat of antimicrobial resistance, writes Eamonn McArdle.…
Conflict in Ukraine leads to disruption to HIV and TB treatmentPeople in Ukraine infected with HIV/AIDS or tuberculosis have faced interrupted treatment, says a UN report on the protracted conflict.…
Faecal transplant therapy delivered effectively by oral capsule Oral delivery of faecal microbiota to eliminate Clostridium difficile infection is as successful as more invasive methods of the treatment.…
Phase II clinical trials for Ebola vaccine planned for early 2015Experts involved in the organisation of clinical research on Ebola vaccines intend to move to randomised controlled phase II trials in early 2015.…
Pneumococcal vaccine reduces antibiotic resistant infections in children by 62% The 13-valent pneumococcal conjugate vaccine (PCV13) has reduced the incidence of antibiotic resistant pneumococcal infections in children.…
Janssen and Novartis pick up 2014 Prix Galien awards Janssen and Novartis scooped prizes at the UK Prix Galien Awards for the first new drug for tuberculosis (TB) in 40 years and the first broadly protective meningitis B vaccine.…